drugset / Trial / NCT00519337
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
Phase 4
Completed
25 enrolled
Hartford Hospital
The Gustavus and Louise Pfeiffer Research Foundation · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-10
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vitamin C | Other / unclassified | 500 mg | Oral |
Indications
No indication recorded.